US FTC Section 13(b) Revamp Gains Traction With Senate ‘Fix’ In The Works
Executive Summary
There is strong support for a bipartisan fix to discourage marketplace fraud and anticompetitive practices and enable consumer redress under the FTC Act. But Congress is distracted and deeply divided with different ideas about how extensive the FTC’s authorities should be under Section 13(b) of the FTC Act.
You may also be interested in...
House Bill Restoring FTC Monetary Relief Tool Stretches ‘Look Back’ Authority From 3 To 10 Years
Limiting FTC authority to enforcement started after legislation passes rather than all pending complaints as House bill allows could be divisive. But consumer health marketers question number of years before a complaint is filed agency can allege a business used false and misleading advertising under legislation the House passed.
Congressional Split Looms Over Including Retroactive Reach In FTC Monetary Relief Authority
Lawmakers disagree whether legislation to amend an FTC regulation to grant the commission authority to pursue monetary remedies should be retroactive, which would impact approximately 75 pending federal court cases alleging violations.
US House Appropriators Seek Data On Fragrance Allergens In Cosmetics, ‘Balance’ In Sunscreen Regs
The House Appropriations Committee asks the US Food and Drug Administration to provide a report to Congress in two years on the resources it would need to develop a database for fragrance allergens used in cosmetics. The committee’s report accompanying FY2023 FDA funding legislation also touches on OTC sunscreen regulation, PFAS in cosmetics, skin-lightening ingredients, and more.